GSK (GSK) announced that the European Medicines Agency, EMA, has granted Priority Medicines, PRIME, Designation for GSK5764227, its ...

Teva Pharmaceutical Industries Ltd. ADR 1.14% $25.35B ...

Revised deal with Zhifei to manage near-term challenges GSK shares marginally lower Potential RSV collaboration for initial 10-year term Dec 5 (Reuters) - China's Zhifei (300122.SZ), opens new tab ...

Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a price target of £16.90. The company’s shares closed today at p1,321. ...

Dec 20 (Reuters) - GSK (GSK.L), opens new tab said on Friday that adding its cancer drug Jemperli to both standard-of-care chemotherapy and Zejula as a maintenance therapy improved survival in ...

Copyright © 2024 MarketWatch, Inc. All rights reserved.

Pharma giant GSK is buying into Rgenta Therapeutics’ mission to develop a pipeline of oral RNA-targeting small molecules. The new partners aim to develop new splice modulators for multiple ...

Rgenta to receive a cash upfront and pre-option milestone payments Rgenta has the potential to receive milestone payments, royalties, and a future equity investment WOBURN, Mass., Dec. 4, 2024 ...

GSK will team up with Boston-area biotech Rgen­ta Ther­a­peu­tics to cre­ate oral small mol­e­cules that tar­get RNA, the com­pa­nies said Wednes­day morn­ing.

After hours: December 27 at 7:38:58 PM EST Loading Chart for GSK ...